InvestorsHub Logo
Followers 70
Posts 1350
Boards Moderated 0
Alias Born 08/12/2014

Re: None

Friday, 07/10/2020 12:23:18 PM

Friday, July 10, 2020 12:23:18 PM

Post# of 730557
It is supposed to be that we are in a quiet period if we are an average small biotech approaching a binary event -- a pivotal phase 3 trial revelation of topline data.

Usually, a company would announce it has reached the threshold, either a required event count or some other pre-specified cutoff rate/ratio/number, then the company would normally have a significant fund raise with a friendly backer, cause nobody would be assure the outcome, and better be prepared for either any possible unpleasant outcome or positive outcome with money on hand, for flexibility in either direction heading towards collapse or FDA approval. After the fund raise, the company would go dark until topline, which ranging from two months to several months (usually three months maximal actually).

Judged by the practice of an average company, we are deep into the quiet period. Regardless whether the company has promised to announce data lock or not, really we are now in the deep quiet period. Unless the company wants to raise fund with the help of data lock announcement, we should hear nothing until topline data.

Any days pass by without news is a good news. It's positive we have not had a significant fund raise yet, and it's positive we have not heard of any other trials, as either backing or distraction -- a common practice of an average small biotech facing such a binary event.

So let's count days that have passed as of today.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News